Mifepristone Derivative FZU-00,003 Suppresses Triplenegative Breast Cancer Cell Growth partially via

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:GalaxyJW
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Triple-negative breast cancer(TNBC)is one of the most malignant breast cancers lacking targeted therapeutics currently due to the heterogeneity of the disease,the absence of well-defined molecular targets and effective targeted therapies.
其他文献
Objective Although 5-Fluorouracil(5-FU),an important clinical cytotoxic chemotherapy drug,has been thought to directly kill cancer cells through inhibiting DNA and RNA synthesis and even play an immun
Objective Nowadays,the immune checkpoint blockades(ICBs)have been widely used in various kinds of tumors and its also such a hot spot in the research area.
目的 本研究旨在研究PLK1 抑制剂BI2536 联合STAT3 抑制剂Stattic 通过MYC 诱导胶质瘤细胞凋亡的分子机制,为靶向PLK1 联合STAT3 治疗胶质瘤提供科学依据。
Objective Objective: PTC is the most common type of thyroid cancer and has a favorable prognosis.However,patients with metastatic radioiodine-refractory papillary thyroid carcinoma(PTC)have limited op
目的 EGFRvⅢ 是胶质母细胞瘤中最常见的突变,具有促进胶质母细胞瘤进展的多种活性。本研究旨在通过体内、外实验揭示SRC 家族激酶抑制剂Saracatinib 对EGFRvⅢ 阳性胶质瘤干细胞的抑制作用。
目的 胃癌是我国最常见的恶性肿瘤,在我国其发病率和死亡率居各类肿瘤的首位,因此,寻找胃癌的治疗靶点是当前肿瘤研究领域的热点.P21 活化蛋白激酶1(p21-activated kinase 1,PAK1)作为I 类PAK 家族的代表,是进化上保守的丝氨酸/苏氨酸蛋白激酶,在肿瘤细胞信号转导过程中具有枢纽作用,因此已成为有效的肿瘤治疗靶点.但目前针对该靶点抑制剂的研究正处于起步阶段.
Objective The molecular mechanism of chemotherapy-resistance in triple-negative breast cancer(TNBC)is unclear.Centrosomal kinase Nek2B is the only Nek2 isomer through the whole process of mitosis.Our
目的 血管内皮生长因子(vascular endothelial growth factor,VEGF)是目前已知的最重要的血管生成调节因子,VEGF 与其受体(vascular endothelial growth factor receptor,VEGFR)特异性结合,调节着血管及肿瘤血管的生成。本研究靶向vegf 及其受体vegfr2 基因 siRNA 对小鼠黑色素瘤细胞B16F10 移植瘤